These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 12227392)

  • 1. Treatment and outcome of peritonitis in automated peritoneal dialysis, using a once-daily cefazolin-based regimen.
    Fielding RE; Clemenger M; Goldberg L; Brown EA
    Perit Dial Int; 2002; 22(3):345-9. PubMed ID: 12227392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Initial treatment of peritoneal dialysis peritonitis without vancomycin with a once-daily cefazolin-based regimen.
    Goldberg L; Clemenger M; Azadian B; Brown EA
    Am J Kidney Dis; 2001 Jan; 37(1):49-55. PubMed ID: 11136167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of intraperitoneal cefazolin and gentamicin in empiric therapy of peritonitis in continuous ambulatory peritoneal dialysis patients.
    Tosukhowong T; Eiam-Ong S; Thamutok K; Wittayalertpanya S; Na Ayudhya DP
    Perit Dial Int; 2001; 21(6):587-94. PubMed ID: 11783768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of vancomycin versus cefazolin as initial therapy for peritonitis in peritoneal dialysis patients.
    Khairullah Q; Provenzano R; Tayeb J; Ahmad A; Balakrishnan R; Morrison L
    Perit Dial Int; 2002; 22(3):339-44. PubMed ID: 12227391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of Intraperitoneal Cefalothin and Cefazolin in Patients Being Treated for Peritoneal Dialysis-Associated Peritonitis.
    Roberts DM; Ranganathan D; Wallis SC; Varghese JM; Kark A; Lipman J; Roberts JA
    Perit Dial Int; 2016; 36(4):415-20. PubMed ID: 26764340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenging the current treatment paradigm for methicillin-resistant Staphylococcus epidermidis peritonitis in peritoneal dialysis patients.
    Ariano RE; Franczuk C; Fine A; Harding GK; Zelenitsky SA
    Perit Dial Int; 2002; 22(3):335-8. PubMed ID: 12227390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent and relapsing peritonitis: causative organisms and response to treatment.
    Szeto CC; Kwan BC; Chow KM; Law MC; Pang WF; Chung KY; Leung CB; Li PK
    Am J Kidney Dis; 2009 Oct; 54(4):702-10. PubMed ID: 19577352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of peritonitis in continuous ambulatory peritoneal dialysis (CAPD) with intraperitoneal cefazolin and gentamicin.
    Weber J; Staerz E; Mettang T; Machleidt C; Kuhlmann U
    Perit Dial Int; 1989; 9(3):191-5. PubMed ID: 2488364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of a non-vancomycin-based peritoneal dialysis peritonitis protocol.
    Toussaint N; Mullins K; Snider J; Murphy B; Langham R; Gock H
    Nephrology (Carlton); 2005 Apr; 10(2):142-6. PubMed ID: 15877673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Once-daily intraperitoneal gentamicin is effective therapy for gram-negative CAPD peritonitis.
    Lye WC; van der Straaten JC; Leong SO; Sivaraman P; Tan SH; Tan CC; Lee EJ
    Perit Dial Int; 1999; 19(4):357-60. PubMed ID: 10507817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraperitoneal once-daily dose of cefazolin and gentamicin for treating CAPD peritonitis.
    Lai MN; Kao MT; Chen CC; Cheung SY; Chung WK
    Perit Dial Int; 1997; 17(1):87-9. PubMed ID: 9068030
    [No Abstract]   [Full Text] [Related]  

  • 12. Ciprofloxacin and cefazolin as a combination for empirical initial therapy of peritoneal dialysis-related peritonitis: five-year follow-up.
    Lima RC; Barreira A; Cardoso FL; Lima MH; Leite M
    Perit Dial Int; 2007; 27(1):56-60. PubMed ID: 17179512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Once-daily intraperitoneal cefazolin and oral ciprofloxacin as empiric therapy for the treatment of peritonitis.
    Troidle L; Gorban-Brennan N; Kliger A; Finkelstein F
    Adv Perit Dial; 1999; 15():213-6. PubMed ID: 10682105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Empirical aminoglycosides for peritonitis do not affect residual renal function.
    Baker RJ; Senior H; Clemenger M; Brown EA
    Am J Kidney Dis; 2003 Mar; 41(3):670-5. PubMed ID: 12612992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of peritonitis in children on peritoneal dialysis: a 25-year experience at Severance Hospital.
    Lee KO; Park SJ; Kim JH; Lee JS; Kim PK; Shin JI
    Yonsei Med J; 2013 Jul; 54(4):983-9. PubMed ID: 23709435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cefazolin plus netilmicin versus cefazolin plus ceftazidime for treating CAPD peritonitis: effect on residual renal function.
    Lui SL; Cheng SW; Ng F; Ng SY; Wan KM; Yip T; Tse KC; Lam MF; Lai KN; Lo WK
    Kidney Int; 2005 Nov; 68(5):2375-80. PubMed ID: 16221243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single UK centre experience on the treatment of PD peritonitis--antibiotic levels and outcomes.
    Blunden M; Zeitlin D; Ashman N; Fan SL
    Nephrol Dial Transplant; 2007 Jun; 22(6):1714-9. PubMed ID: 17369615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraperitoneal vancomycin plus levofloxacin for the treatment of peritoneal dialysis-related peritonitis in patients with no response to cefazolin plus ceftazidime.
    Zhou J; Huang Y; Zhang X; Xiong L; Zhang R; Shi H
    Clin Nephrol; 2024 Apr; 101(4):164-170. PubMed ID: 38329920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of peritoneal dialysis catheter infections in Saudi peritoneal dialysis patients: the emergence of high-level mupirocin resistance.
    Al-Hwiesh AK; Abdul-Rahman IS; Al-Muhanna FA; Al-Sulaiman MH; Al-Jondebi MS; Divino-Filho JC
    Int J Artif Organs; 2013 Jul; 36(7):473-83. PubMed ID: 23897229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraperitoneal cefazolin and ceftazidime during short-dwell exchange in peritoneal dialysis patients with peritonitis.
    Triyawatanyu P; Chariyavilaskul P; Phaisal W; Peerapornratana S; Kanjanabuch T; Praditpornsilpa K; Katavetin P
    Perit Dial Int; 2020 Mar; 40(2):179-184. PubMed ID: 32063189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.